138657-11-1 Usage
Uses
Used in Pharmaceutical Industry:
Pyridinium, 1-(6-methoxy-1-methyl-1H-benzimidazol-2-yl)-2,4,6-triphenyl-, iodide is used as a potential pharmaceutical agent for its unique structural features that may contribute to the development of new drugs targeting specific biological pathways or receptors.
Used in Materials Science:
In the field of materials science, Pyridinium, 1-(6-methoxy-1-methyl-1H-benzimidazol-2-yl)-2,4,6-triphenyl-, iodide may serve as a component in the design of novel materials with tailored properties, such as光电材料 (photoelectric materials) or 传感材料 (sensing materials), due to its specific chemical structure and functional groups.
Used in Organic Synthesis:
Pyridinium, 1-(6-methoxy-1-methyl-1H-benzimidazol-2-yl)-2,4,6-triphenyl-, iodide is utilized as an intermediate or a reagent in organic synthesis processes, facilitating the creation of more complex molecules or providing a platform for further chemical modifications.
Check Digit Verification of cas no
The CAS Registry Mumber 138657-11-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,6,5 and 7 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 138657-11:
(8*1)+(7*3)+(6*8)+(5*6)+(4*5)+(3*7)+(2*1)+(1*1)=151
151 % 10 = 1
So 138657-11-1 is a valid CAS Registry Number.
138657-11-1Relevant academic research and scientific papers
NMR studies of N-(benzimidazol-2-yl)pyridinium derivatives: QSAR with the anti-leishmanial activity and their carbon-13 NMR chemical shifts
Alcalde, E,Dinares, I,Frigola, J
, p. 633 - 642 (2007/10/02)
Quantitative structure-activity-relationships between the in vitro anti-leishmanial activity of N-benzimidazolyl-2,4,6-triphenylpyridinium salts 6 and pyridinium benzimidazolate betaines 7 and their 13C-NMR chemical shifts have been studied, in order to ascertain the influence of the benzimidazole substituents upon anti-leishmanial activity.The calculated 13C-chemical shifts allow the selection of a representative subset of compounds.Several new N-benzimidazolylpyridinium derivatives 6 and 7 have been prepared.Among them, 5-methoxy-1-methylbenzimidazole 21 and 6-methoxy-1-methylbenzimidazole 22 derivatives have high anti-leishmanial activity in vitro and compound 22 shows an interesting activity in vivo although host toxicity is present.
